The Valley Desk

NCT02091141 · Interventional trial

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

Overall registry status Completed

Phase 2

Conditions Biliary Cancer, Bladder Cancer, Neoplasms, Salivary Cancer, Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov